GLP-1-based therapies for the treatment of resistant hypertension in individuals with overweight or obesity: a review.
針對超重或肥胖個體的抗藥性高血壓治療的GLP-1基礎療法:一項綜述。
EClinicalMedicine 2024-09-09
Incidence of new onset type 2 diabetes in adults living with obesity treated with tirzepatide or semaglutide: real world evidence from an international retrospective cohort study.
肥胖成人使用 tirzepatide 或 semaglutide 治療的新發型 2 糖尿病發生率:來自國際回顧性隊列研究的實證證據。
EClinicalMedicine 2024-09-09
Factors Correlated to the Renoprotective Effect of Sitagliptin in Patients with Type 2 Diabetes Mellitus: Retrospective Observational Study.
與 Sitagliptin 在 2 型糖尿病患者中腎保護效果相關的因素:回顧性觀察研究。
Adv Pharmacol Pharm Sci 2024-09-09
Time-in-range derived from self-measured blood glucose in people with type 2 diabetes advancing to iGlarLixi: A participant-level pooled analysis of three phase 3 LixiLan randomized controlled trials.
從自我測量血糖得出的時間範圍在進入 iGlarLixi 的 2 型糖尿病患者中的應用:三項第 3 期 LixiLan 隨機對照試驗的參與者層級匯總分析。
Diabetes Obes Metab 2024-09-08
High-dimensional Iterative Causal Forest (hdiCF) for Subgroup Identification Using Health Care Claims Data.
使用健康保險索賠數據的高維迭代因果森林 (hdiCF) 進行亞群體識別。
Am J Epidemiol 2024-09-08
Obstructive sleep apnea and obesity: A review of epidemiology, pathophysiology and the effect of weight-loss treatments.
阻塞性睡眠呼吸暫停症與肥胖:流行病學、病理生理學及減重治療效果的綜述。
Sleep Med Rev 2024-09-08
Principal components analysis on genes related to inflammasome complex and microglial activation in the hypothalamus of obese mice treated with semaglutide (GLP-1 analog).
在接受semaglutide(GLP-1 類似物)治療的肥胖小鼠下丘腦中,與炎症小體複合體和小膠質細胞活化相關基因的主成分分析。
Brain Res 2024-09-07
Absorption, Distribution, Metabolism, and Excretion of Tirzepatide in Humans, Rats, and Monkeys.
Tirzepatide 在人類、老鼠和猴子中的吸收、分佈、代謝和排泄。
Eur J Pharm Sci 2024-09-07